Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.0K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Seizures: Classification01:13

Seizures: Classification

1.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

521
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
521
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

714
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
714
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

568
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
568
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

787
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
787

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serine Biosynthesis Defect: A Treatable Neurometabolic Disorder.

Indian journal of pediatrics·2026
Same author

SEMA6B-Related Progressive Myoclonic Epilepsy Mimicking Angelman Syndrome.

Movement disorders clinical practice·2026
Same author

Phenotypic Exploration in Patients with Heterozygous Variant in AFG3L2 Gene: A Case-Series and Literature Review.

Movement disorders clinical practice·2026
Same author

GLUT1 Deficiency Syndrome with Coexistent Movement Disorder and Anemia.

Movement disorders clinical practice·2026
Same author

Electroencephalographic Abnormalities in Children with Single Calcified Neurocysticercosis Lesion: A Cross-Sectional Study.

Neurology India·2026
Same author

Accuracy of Telephone-Based Follow-Up in Identifying Critical Events in Children With Duchenne Muscular Dystrophy Receiving Standard of Care.

Muscle & nerve·2026
Same journal

Bilateral Parotid Enlargement as an Initial Manifestation of Pediatric Acute Lymphoblastic Leukemia.

Indian journal of pediatrics·2026
Same journal

Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia: Authors' Reply.

Indian journal of pediatrics·2026
Same journal

A Prospective Model for Detecting Missed Appendicitis in Low-Risk Pediatric Patients: Correspondence.

Indian journal of pediatrics·2026
Same journal

Serum Periostin as a Biomarker in Pediatric Asthma: Findings from a Case-Control Study - Authors' Reply.

Indian journal of pediatrics·2026
Same journal

When the Eye Peels: An Unusual Harbinger of Kawasaki Disease - Correspondence.

Indian journal of pediatrics·2026
Same journal

Pediatric Sleep-Related Laryngospasm: Cause of Nocturnal Respiratory Distress.

Indian journal of pediatrics·2026
See all related articles

Related Experiment Video

Updated: Dec 19, 2025

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
13:34

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice

Published on: June 4, 2020

8.7K

Epilepsy, cognition and behavior.

Sheffali Gulati1, Sangeetha Yoganathan, Biswaroop Chakrabarty

  • 1Division of Pediatric Neurology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India, sheffaligulati@gmail.com.

Indian Journal of Pediatrics
|July 31, 2014
PubMed
Summary
This summary is machine-generated.

Epilepsy often leads to cognitive and behavioral issues, impacting learning, memory, and causing anxiety or depression. Early identification and tailored treatments, including medication and immunotherapy, are crucial for managing these comorbidities in epilepsy patients.

More Related Videos

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

10.0K
Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex
09:00

Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex

Published on: April 15, 2015

12.7K

Related Experiment Videos

Last Updated: Dec 19, 2025

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
13:34

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice

Published on: June 4, 2020

8.7K
Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

10.0K
Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex
09:00

Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex

Published on: April 15, 2015

12.7K

Area of Science:

  • Neurology
  • Neuroscience
  • Pediatric Neurology

Background:

  • Epilepsy, defined by recurrent unprovoked seizures, is frequently associated with significant cognitive and behavioral impairments.
  • These comorbidities affect up to 25% (cognitive) and 75% (behavioral) of epilepsy patients.
  • Factors contributing to these impairments include etiology, environment, seizure characteristics, and treatment side effects.

Purpose of the Study:

  • To highlight cognitive epilepsy as a distinct entity.
  • To outline the spectrum of cognitive and behavioral deficits in epilepsy.
  • To discuss the challenges and rational approaches to managing these comorbidities.

Main Methods:

  • Review of factors implicated in cognitive and behavioral impairment in epilepsy.
  • Description of cognitive epilepsy manifestations (transient changes, encephalopathy, nonconvulsive status epilepticus).
  • Identification of common cognitive deficits (learning, memory, problem-solving) and psychiatric comorbidities (anxiety, depression, ADHD).

Main Results:

  • Cognitive impairment in epilepsy includes difficulties in learning, memory, problem-solving, and concept formation.
  • Common psychiatric comorbidities include anxiety, depression, and attention deficit hyperkinetic disorders.
  • Investigating these impairments in children presents challenges due to cooperation requirements.

Conclusions:

  • Cognitive and behavioral comorbidities are prevalent in epilepsy and require thorough investigation.
  • A rational treatment approach involves judicious antiepileptic drug selection, addressing the underlying cause, managing behavioral issues, and considering immunotherapy for cognitive epilepsies.
  • Early and comprehensive management is essential for improving outcomes in patients with epilepsy and associated comorbidities.